51. The Worldwide Next Generation Diabetes Therapy and Drug Delivery Industry is Expected to Reach $28 Million by 2030
- Subjects
DexCom Inc. -- Forecasts and trends -- Reports ,Medtronic PLC -- Forecasts and trends -- Reports ,Johnson & Johnson -- Forecasts and trends -- Reports ,Mannkind Corp. -- Forecasts and trends -- Reports ,Eli Lilly and Co. -- Forecasts and trends -- Reports ,Novo Nordisk A/S -- Forecasts and trends -- Reports ,Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends -- Reports ,Drugs -- Vehicles ,Diabetes therapy -- Statistics -- Reports ,Medical test kit industry -- Forecasts and trends -- Statistics -- Reports ,Medical equipment and supplies industry -- Forecasts and trends -- Statistics -- Reports ,Type 2 diabetes -- Drug therapy -- Reports ,Drug delivery systems -- Statistics -- Reports ,Pharmaceutical industry -- Statistics -- Forecasts and trends -- Reports ,Market trend/market analysis ,General interest ,News, opinion and commentary - Abstract
DUBLIN: Research and Markets has issued the following news release: The 'Next Generation Diabetes Therapy and Drug Delivery Market By Product, By Demographic, By Indication, By End User: Global Opportunity [...]
- Published
- 2022